Stanford University
Showing 20,001-20,100 of 35,013 Results
-
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Alexandria McPherson
Postdoctoral Scholar, Psychology
BioAlexandria (Xan) McPherson is a postdoctoral researcher in the Department of Psychology at Stanford University. Xan completed her PhD in Applied Physics at the University of Washington, I-LABS with Dr. Samu Taulu as her advisor. There, she developed improvements to the methodology and instrumentation for on-scalp MEG systems, such as OPM-MEG, with the goal of implementing reliable and robust methods for OPM data collection and processing. During her postdoc, she is continuing her work on OPM-MEG systems with Dr. Laura Gwilliams to further the study of speech comprehension.
-
Alison McQueen
Associate Professor of Political Science and, by courtesy, of History
BioAlison McQueen is the the Nehal and Jenny Fan Raj Civics Faculty Fellow in Undergraduate Teaching and an Associate Professor in the Department of Political Science at Stanford University. Her research focuses on early modern political theory and the history of International Relations thought.
McQueen’s book, Political Realism in Apocalyptic Times (Cambridge University Press, 2018), traces the responses of three canonical political realists—Niccolò Machiavelli, Thomas Hobbes, and Hans Morgenthau—to hopes and fears about the end of the world. A second book project, Absolving God: Hobbes’s Scriptural Politics, tracks and explains changes in Thomas Hobbes’s strategies of Scriptural argument over time. She is also working on treason and betrayal in the history of political thought. -
Sarah McShea
Program Manager, Community Engaged Learning and Research, Haas Center for Public Service
Current Role at StanfordCommunity Engaged Learning and Research Program Manager
-
Mark Patrick McVay
Temp - Non-Exempt, Contingent
Staff, Stanford Doerr School of Sustainability - Dean's OfficeBioMark joined Stanford Energy in January of 2020 to focus on business model innovation supporting energy transformation. He is working with students and faculty throughout Stanford on efforts to create solutions for Carbon Reduction and Sustainability goals in large organizations. He is now working with Doerr School of Sustainability on external relations. Mark has spent his career in energy starting as a nuclear power engineer aboard an aircraft carrier. He most recently helped build and sell the energy analytics firm PowerAdvocate and currently serves on the boards of several energy related small companies. Mark earned an MBA from the Stanford GSB and an MS from the School of Engineering. He has a BS from the US Naval Academy.
-
Kimford Meador, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
BioDr. Meador is a Professor of Neurology and Neurosciences at Stanford University, and Clinical Director, Stanford Comprehensive Epilepsy Center. Dr. Meador graduated from the Georgia Institute of Technology in Applied Biology (with high honor) and received his MD from the Medical College of Georgia. After an internship at the University of Virginia and service as an officer in the Public Health Corps, he completed a residency in Neurology at the Medical College of Georgia and a fellowship in Behavioral Neurology at the University of Florida. Dr. Meador joined the faculty at the Medical College of Georgia (1984-2002) where he became the Charbonnier Professor of Neurology. He was the Chair of Neurology at Georgetown University (2002-2004), the Melvin Greer Professor of Neurology and Neuroscience at the University of Florida (2004-2008) where he served as Director of Epilepsy Program and Director of the Clinical Alzheimer Research Program, and Professor of Neurology and Pediatrics at Emory University (2008-2013) where he served as Director of Epilepsy and of Clinical Neurocience Research. He joined the faculty of Stanford University in 2013. Dr. Meador has authored over 400 peer-reviewed publications. His research interests include: cognitive mechanisms (e.g., memory and attention); cerebral lateralization; pharmacology and physiology of cognition; mechanisms of perception, consciousness and memory; EEG; epilepsy; epilepsy and pregnancy; preoperative evaluation for epilepsy surgery; intracarotid amobarbital procedure (i.e., Wada test); functional imaging; therapeutic drug trials; neurodevelopmental effects of antiepileptic drugs; psychoimmunology; behavioral disorders (e.g., aphasia, neglect, dementia); and neuropsychiatric disorders. Dr. Meador has served as the PI for a long running NIH multicenter study of pregnancy outcomes in women with epilepsy and their children. Dr. Meador has served on the editorial boards for Clinical Neurophysiology, Epilepsy and Behavior, Epilepsy Currents, Journal of Clinical Neurophysiology, Neurology, Cognitive and Behavioral Neurology, and Epilepsy.com. His honors include Resident Teaching Award Medical College of Georgia; Outstanding Young Faculty Award in Clinical Sciences Medical College of Georgia; Distinguished Faculty Award for Clinical Research Medical College of Georgia Lawrence C. McHenry History Award American Academy of Neurology; Dreifuss Abstract Award American Epilepsy Society; Fellow of the American Neurological Association; Diplomat of American Neurologic Association; past Chair of the Section of Behavioral Neurology of American Academy of Neurology; past President of Society for Cognitive and Behavioral Neurology; past President of the Society for Behavioral & Cognitive Neurology; past President of the Southern EEG & Epilepsy Society; ranking in the top 10 experts in epilepsy worldwide by Expertscape; Distinguished Alumnus Award for Professional Achievement, Medical College of Georgia, Georgia Regents University 2015; American Epilepsy Society Clinical Research Award; and named award by the American Epilepsy Society: “Kimford J. Meador Research in Women with Epilepsy Award,” and ranked in the top 500 neuroscientist in the world and top 300 in USA by Research.com in 2022.
-
Peter Meaney
Clinical Professor, Pediatrics - Critical Care
Affiliate, Pediatrics - Peds/Critical CareCurrent Research and Scholarly InterestsDr. Meaney focuses on improving how clinically serious interventions are adopted, implemented, and scaled in real-world care environments. His work spans clinical workflow, behavior change, and performance systems, with emphasis on why clinically valid approaches fail to translate into sustained use. He develops and deploys implementation models that align product, workflow, and stakeholder incentives to enable adoption across complex health systems.
-
David Medeiros
Geospatial Reference and Instruction Specialist, Geospatial Information Services
BioI am the Geospatial Reference and Instruction Specialist for the Stanford Geospatial Center, part of the Research Data Services group. I provide GIS consultation and reference support to Stanford students, faculty and staff. My primary role is supporting Stanford researchers in their use and understanding of geospatial tools, data, and methods.
Much of my time is spent conducting one-on-one consultations, training users on GIS software, finding spatial data, and helping design spatial analysis. In addition to one-on-one consultations I also coordinate and present our ongoing series of workshops in GIS (Introduction to GIS, Georeferencing, ArcGIS Online 101, GIS Cartography).
My educational background is in Geography and Geographic Information Science, but a significant part of my professional background is in digital cartography. I have a strong interest in the effective use of design in map making for GIS. I am available for faculty publication map support as well as novel geospatial design work with tools like Blender3d or 3d printing of spatial data. -
Rishi Mediratta
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsI have developed a new promising neonatal mortality prediction score at the University of Gondar Neonatal Intensive Care Unit (NICU) in Gondar, Ethiopia. The score predicts approximately 84% of neonatal deaths in the NICU using clinical variables. I have a dataset over 800 NICU admissions in Gondar. I am recruiting scholars who are interested in conducting clinical and epidemiological research to validate, refine, and implement the mortality score to reduce neonatal mortality in Ethiopia.
-
Sangeeta Mediratta
Lecturer, Program in Writing and Rhetoric
BioSangeeta Mediratta teaches classes on rhetoric and writing, literature and film. Her PWR classes currently focus on maps, borders, networks, objects, and objectification. She loves learning about and helping her students develop their research interests and projects and takes great joy in fostering strong class communities centered around writing and research.
She completed her Ph.D. from University of California, San Diego in English Literature. Her dissertation :Bazaars, Cannibals, and Sepoys: Sensationalism and Transnational Cultures of Empire" studied at the ways texts, objects, and spectacles in the U.S. and Britain drew upon imperial stories and objects to critique contemporary social formations. She has also written on world cinema, popular culture, disability studies, as well as gender and race studies.
Her current research focuses on the materiality of writing and on how students use culture as a way to build campus communities. She is also interested in empathy as a mode of living, connecting, writing, and being. -
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Eric Meffre
Professor of Medicine (Immunology and Rheumatology)
BioDr. Meffre obtained his PhD in Immunology from the Université d’Aix-Marseille in France before he moved to the USA as a postdoc fellow in the laboratory of Dr. Michel Nussenzweig at The Rockefeller University in New York City. He became an assistant professor at Cornell University in 2003 before being recruited at Yale University as associate professor in 2009. He was tenured at Yale in 2014 before he joined the Department of Medicine/Division of Immunology and Rheumatology at Stanford University as a tenured full professor in 2022.
Dr. Meffre’s work focuses on the etiology of autoimmune syndromes and the roles played by B cells in these diseases. His group characterized the abnormal selection of developing autoreactive B cells in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), multiple sclerosis (MS) and Sjögren’s syndrome, resulting in large numbers of autoreactive naïve B cells accumulating in the patient’s blood. Hence, these autoreactive B cells may present self-antigens to T cells and initiate autoimmune diseases. These early B cell tolerance defects are likely primary to these autoimmune diseases and may result from genetic factors such as the 1858T PTPN22 allele that segregates with RA, SLE and T1D and correlate with an impaired removal of developing autoreactive B cells.
His research goals also consist in characterizing the molecules and pathways involved in the establishment of B cell tolerance and the removal of developing autoreactive B cells generated by random V(D)J recombination through the investigation of rare patients with primary immunodeficiency (PID) enrolled through an international network. Alteration of B cell receptor (BCR) or Toll-like receptor (TLR) signaling in PID patients results in a defective central B cell tolerance and a failure to counterselect developing autoreactive B cells in the bone marrow. In contrast, functional and suppressive regulatory T cells play a key role in preventing the accumulation of autoreactive clones in the mature naïve B cell compartment. The recent development of humanized mouse models recapitulating early B cell tolerance checkpoints and their defects in autoimmune settings allow further in-depth investigation of tolerance mechanisms and the development of novel approaches to restore defective central and peripheral B cell tolerance checkpoints and thwart autoimmunity. -
Jessica Lee Mega
Affiliate, Medicine - Med/Cardiovascular Medicine
BioJessica L. Mega, MD, MPH is a leader at the intersection of technology, life science, and health. She is a Cardiologist at Stanford and serves on the Advisory Board for Stanford's Center for Digital Health. She is a Co-Founder of Alphabet's Verily and former Chief Medical Officer of Google Life Sciences. She is on the Board of Directors at Boston Scientific, as well as the Board of Advisors for Research!America and the Duke-Margolis Center for Health Policy. She is a Senior Advisor at SandboxAQ and the Chair of the Investment Committee of the American Heart Association’s GRFW Venture Fund.
As a faculty member at Harvard Medical School, a Senior Investigator with the TIMI Study Group, and a Cardiologist at Brigham and Women’s Hospital, Dr. Mega led large, international, randomized trials evaluating novel therapies and new medical technologies. She directed the TIMI Study Group’s Genomics Program, demonstrating and testing the role of CYP2C19 genetic variants on antiplatelet medications, a key pharmacogenetic finding. She has published manuscripts in the New England Journal of Medicine, Lancet, and JAMA. She served as an Advisor for the California Governor’s Precision Medicine Initiative and the Board of Directors at Danaher Corporation.
Dr. Mega is a graduate of Stanford University, Yale University School of Medicine, and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association and the American College of Cardiology. -
Uchechukwu Megwalu, MD, MPH
Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsOutcomes Research
Health Disparities
Comparative Effectiveness Research
Health Literacy
Head and Neck Cancer Epidemiology
SEER database analysis -
Thulaj Dattatraya Meharwade
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Thulaj Meharwade is a postdoctoral fellow at the Stanford Cardiovascular Institute with research interests in Inflammaging, disease modeling, cellular heterogeneity and drug discovery. Dr. Meharwade received his PhD in Biochemistry from the University of Montreal, after conducting thesis work on signalling and transcriptional mechanisms regulating cell fate heterogeneity and totipotent stem cells.
-
Rania Zuri
Undergraduate, Vice Provost for Undergraduate Education
BioRania Zuri is the founder and CEO of The LiTEArary Society, the world’s largest youth-led nonprofit organization working to end book deserts for disadvantaged preschool children. To date, The LiTEArary Society has donated more than $1 million worth of brand new books to over 91,000 disadvantaged preschool children in all 50 states. The LiTEArary Society has partnerships and has received funding from Scholastic, Inc., Barnes & Noble, L'Oréal, Hershey’s, Pilot Pens, and Starbucks.
For her work in early childhood literacy, she has been featured on Good Morning America, Forbes, NBC Nightly News with Lester Holt, The Today Show, The Kelly Clarkson Show (x2), CBS Evening News, NPR, Fox News, Teen Vogue, The Washington Post, NowThis, The Hill, People Magazine, and more.
She was named by Forbes as one of "Six Teens Making the World a Better Place” in 2022 and made the Forbes 30 under 30 list in 2024 as the youngest CEO on the entire list. In 2023, Rania received The Diana Award, one of the most prestigious international accolades a young person (ages 8 to 25) can receive for social or humanitarian work and was one of only 3 recipients out of the 189 global recipients to be introduced by Prince Harry. In 2023, Rania was honored at the White House by the First Lady of the United States as a "Girl Leading Change" in celebration of International Day of the Girl. Most recently, Rania was honored by L'Oréal Paris as a L’Oréal Woman of Worth, L'Oréal's signature philanthropic initiative which honors 10 female leaders each year.
Rania has given a TEDx Talk on book deserts with over 43,000 views on TED.com and Youtube and was the keynote speaker at the annual WV Head Start Conference. She has written op-eds for Teen Vogue and NBC News Online on education as well. She serves as an ambassador for many organizations and corporations, including the United Nations Association (as a UNA-USA Global Goals Ambassador for Sustainable Development Goal #4).
She is the youngest author of a US Senate Resolution in U.S. history and has written a children’s picture book series (sold in-store at select Barnes & Noble stores) where 100% of the profits go to the purchase of brand-new Scholastic books for preschool children in Head Start programs.
Rania is a Coca-Cola Scholar, a U.S. Presidential Scholar, a Cameron Impact Scholar, a Taco Bell Live Mas Scholar, winner of the Gloria Barron Prize for Young Heroes, and has received 3 US Congressional Commendations as well as the George H.W. Bush Point of Light Award. -
Anay Mehrotra
Postdoctoral Scholar, Management Science and Engineering
BioI am a Postdoctoral Scholar at Stanford, where I am excited to work with Amin Saberi. I completed my Ph.D. at Yale University where I was fortunate to be advised by Amin Karbasi and Manolis Zampetakis.
My research focuses on machine learning under complex conditions where traditional assumptions break down. My work has two parts. First, I develop foundations for machine learning with missing and selectively observed data (spanning causal inference, limited-dependence, truncated statistics, and omissions shaped by societal biases). Second, I study why generative AI systems (including language models) are effective and design methods to evaluate and improve their safety.
My work has received the Best Paper Award at COLT, been featured in WIRED, and received the Sir Binay Kumar Sinha award from IIT Kanpur. As an undergraduate, I represented IIT Kanpur at the ICPC World Final. While at Yale, I also taught at the Yale ICPC Club. -
Apurva Mehta
Senior Scientist, LCLS - Linac Coherent Light Source
Current Role at StanfordHead of Material Sciences Department
Linac Coherent Light Source
SLAC national accelerator lab -
Arnav Mehta, MD, PhD
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioDr. Mehta is a board-certified, fellowship-trained medical oncologist at the Stanford Medicine Cancer Center. He is also an adjunct clinical assistant professor in the gastrointestinal (GI) oncology group of the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Mehta specializes in gastrointestinal cancer, with a particular focus on pancreatic and gastric cancers. He also treats colorectal cancers. His treatment specialties include immunotherapy — helping a patient’s immune system fight cancer — and targeted therapies, which send cancer-fighting drugs to specific cancer cell molecules.
His research interests include understanding why GI cancers resist treatments and identifying new ways to treat these tumors. In particular, he is interested in GI tumor immunology, which focuses on directing a person’s immune system to help destroy cancer cells. He also has a special interest in tumor plasticity, which represents the ability of a tumor cell to evolve and develop resistance to therapies.
Dr. Mehta has earned research awards and grants from organizations including the American Association for Cancer Research (AACR), American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), and the National Institutes of Health.
Dr. Mehta has published in many peer-reviewed journals, including Nature, Nature Genetics, Nature Immunology, Nature Medicine, Nature Cancer, Cancer Discovery and Immunity. He has written book chapters on subjects including esophageal and gastric cancer. He has also presented his research on topics including tumor immunology and pancreatic cancer at dozens of symposia and meetings around the country.
Dr. Mehta is a member of the AACR and ASCO. -
Niraj Mehta
MBA, expected graduation 2027
Current Research and Scholarly InterestsPlants provide some of the most important drugs in current clinical use. It can be challenging to chemically synthesize these drugs or sustainably source them from producer plants. These issues could be alleviated if their biosynthetic genes are engineered into heterologous organisms for large-scale production. I am interested in a) understanding how plants produce these valuable drugs and b) engineering the sustainable production of these drugs into other plants for large-scale production.
